Jade Biosciences
Jade Biosciences is a biotechnology company focused on developing best-in-class therapies for autoimmune diseases. The company launched in July 2024 and has a portfolio engineered by Paragon Therapeutics. Its goal is to redefine the standard of care for these diseases.
Buy Download
Funding Round:
Funding Amount: $95M
Date: 24-Oct-2024
Investors: Fairmount, Venrock Healthcare Capital Partners, Deep Track Capital, Driehaus Capital Management, Franklin Templeton, RTW Investments, Braidwell LP, Frazier Life Sciences, Versant Ventures
Markets: Biotechnology, Pharmaceuticals
HQ: Vancouver, British Columbia, Canada
Founded: 2024
Website: https://jadebiosciences.com/
LinkedIn: https://www.linkedin.com/company/jade-biosciences/
Leave a Comment
Comments
No comments yet.